"New Study Will Evaluate Effect of Workplace Lifestyle Intervention on CV Risk Factors"
Researchers have launched a 3-year study to determine whether a workplace-based lifestyle intervention, accompanied by imaging data, will lead to a reduction in the prevalence of CVD risk factors. The TANSNIP-PESA study will be led by Valentin Fuster, MD, PhD, director of Mount Sinai Heart and Physician-in-Chief of The Mount Sinai Hospital. The study will enroll adults aged 40 to 60 years at a corporation in Spain. Learn more.
Valentin Fuster, MD, PhD, Receives Prestigious Award from City of Barcelona, Spain
Jan 23, 2023 View All Press ReleasesSamin Sharma, MD, Named Director of the Mount Sinai Cardiovascular Clinical Institute
Nov 28, 2022 View All Press ReleasesValentin Fuster, MD, PhD, Named President of Mount Sinai Heart
Oct 18, 2022 View All Press Releases